Here are four things to know. 1. Levetiracetam is intended to treat partial onset seizures related to epilepsy. 2. The tablets are a generic equivalent to UCB’s brand name drug Keppra XR. 3. Sales of ...

MUMBAI, May 23 (Reuters) - Drug maker Alembic Ltd. said on Wednesday it had signed a deal to out-license its novel drug delivery platform to Belgium's UCB for the latter's anti-epileptic drug Keppra ...

Doses are prepared in 500mg/100mL, 1,000 mg/100mL and 1,500 mg/100mL sizes and packaged in ready-to-use bags--a first-of-its-kind drug-delivery concept for Levetiracetam, new Mylan CEO Heather Bresch ...

January 25, 2012 — The US Food and Drug Administration (FDA) has given the go-ahead for the use of levetiracetam (Keppra, UCB Pharmaceuticals) as adjunctive treatment for partial-onset seizures in ...

Dec. 9, 2003 (Boston) -- An unknown number of physicians prescribe levetiracetam (Keppra) off-label as a single-drug therapy for epilepsy, but researchers in California and Minnesota have found cause ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...